End of Bull Run in U.S. Stocks Poses Threat to Emerging Markets
(Bloomberg) -- It's as if the game were rigged. When U.S. equities rallied earlier this year, emerging-market stocks fell, and when U.S. equities declined in the past month, their developing-nation counterparts tumbled even more.
As U.S. stocks threaten to end a decade-long bull market, the outlook is growing worse for emerging markets, according to Morgan Stanley strategists led by James Lord and Simon Waever. The firm's cross-asset team is underweight developing-nation shares.
"Risk off in the S&P means risk off everywhere," said Anastasia Levashova, a fund manager at Blackfriars Asset Management in London. "Any profit-taking in U.S. stocks means a run into the dollar and selling EM currencies and stocks."
Last month, when the S&P 500 Index slid 6.9 percent in its worst monthly decline since September 2011, 15 of the 17 emerging-market equity indexes tracked by Morgan Stanley also fell. Only shares from Brazil and Hungary showed resilience.
It was a similar story for currencies, with the noticeable exceptions of the Argentine peso, the Turkish lira and Brazilian real. Levashova said they have a temporary advantage after posting some of the world's biggest losses earlier in the year, driven by domestic headlines. At current valuations, they're potential havens in the event of a gradual slide in U.S. stocks, she said.
"If it's a panic selloff, they will all tank," Levashova said.
To contact the reporter on this story: Ben Bartenstein in New York at bbartenstei3@bloomberg.net
To contact the editors responsible for this story: Rita Nazareth at rnazareth@bloomberg.net, Philip Sanders, Brendan Walsh
©2018 Bloomberg L.P.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.
-
Why Amazon And Flipkart Are Struggling To Beat Meesho In India's Smaller Cities
With 274 million users and lowest-cost logistics, Meesho is defending its value commerce crown against giants like Amazon and Flipkart.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Swiggy vs Eternal: Food Delivery's Two Rivals Are No Longer In The Same Race
Eternal is building a private AI assistant, dark.ai. Swiggy is still working out how to make Instamart pay, with an operating loss of Rs 895 crore in the July-September quarter while Blinkit stayed profitable.
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.
-
France's Economy & Politics Are In Crisis | The Reason Why
Let's look at how the French economy and politics evolved under Nicolas Sarkozy, Franois Hollande and Emmanuel Macron.